BAYLOR COLLEGE OF MEDICINE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
- Conditions
- Non-Melanomatous Skin Cancer
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 175
- Registration Number
- NCT00003097
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
- Conditions
- Neuroblastoma
- Interventions
- Biological: EBV specific CTLs
- First Posted Date
- 2004-06-21
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT00085930
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)
- Conditions
- Lymphoma
- Interventions
- Biological: CD45 antibodiesBiological: EBV specific T cells
- First Posted Date
- 2004-05-05
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 4
- Registration Number
- NCT00082225
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸The Methodist Hospital, Houston, Texas, United States
EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
- Conditions
- Nasopharyngeal CancerEBV Infections
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT00078546
- Locations
- 🇺🇸
The Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
- Conditions
- Cytomegalovirus Infections
- Interventions
- Biological: CMV CTL infusion
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2014-10-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT00078533
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
- Conditions
- LeukemiaLeukemia, B-Cell, Chronic
- Interventions
- Biological: Dose Level 1Biological: Dose Level 2- Fixed DoseBiological: Dose Level 2
- First Posted Date
- 2004-03-02
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 9
- Registration Number
- NCT00078520
- Locations
- 🇺🇸
The Methodist Hospital, Houston, Texas, United States
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
- First Posted Date
- 2003-12-18
- Last Posted Date
- 2012-11-12
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT00074607
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
🇺🇸National Cancer Institute, Bethesda, Maryland, United States
Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
- Conditions
- Kidney Cancer
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2015-01-29
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT00073879
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 7
- Registration Number
- NCT00069992
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸The Methodist Hospital, Houston, Texas, United States
Study of Antioxidants and Oxidants in Malnourished Children
- Conditions
- KwashiorkorProtein-energy MalnutritionMarasmus
- Interventions
- Dietary Supplement: sulfur amino acids
- First Posted Date
- 2003-09-17
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 86
- Registration Number
- NCT00069134
- Locations
- 🇯🇲
Tropical Metabolism Research Unit, University of the West Indies, Kingston, Saint Andrew, Jamaica